| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |